Coherus BioSciences
In Howard Marks's portfolio · Oaktree Capital Management
Ticker CHRS.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2025 | Sell | 0 | |
| Q1 2025 | No change | 49,030,000 | 0.9% |
| Q4 2024 | Add 7% | 49,030,000 | 0.8% |
| Q3 2024 | Add 1215% | 46,030,000 | 0.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.